Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)
Mila Kunis Helps Miner Become Top Emerald Producer
54:51 - Gemfields CEO Ian Harebottle discusses the gemstone business with Bloomberg's Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • Redfin CEO: How Apple Watch Will Change My Business
  • Is OrangeTheory the Next Big Thing in Fitness Data?
  • Behind the Documentary 'All Eyes and Ears'